Therefore, SEMA3F, NRP1 and NRP2 expression was correlated with molecular and clinical parameters in two datasets from the Gene Expression Omnibus (GEO) database [45] and in a BC patient cohort from the Institute for Cancer Research, Oslo (Norway) [48]. The gene discussed is SEMA3F; the disease is breast cancer.